老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Zentalis Pharmaceuticals, LLC

3.08
-0.0200-0.65%
盤後：3.120.0400+1.30%19:50 EDT
成交量：109.07萬
成交額：336.93萬
市值：2.92億
市盈率：-1.57
高：3.22
開：3.18
低：3.02
收：3.10
52周最高：6.95
52周最低：1.21
股本：9,467.19萬
流通股本：7,528.59萬
量比：1.08
換手率：1.45%
股息：- -
股息率：- -
每股收益(TTM):-1.9591
每股收益(LYR):-1.9100
淨資產收益率：-66.75%
總資產收益率：-33.15%
市淨率：2.03
市盈率(LYR):-1.61

資料載入中...

總覽公司新聞資訊公告
2020/10/02

重要事件披露

8-K - Current report
2020/08/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/13

重要事件披露

8-K - Current report
2020/07/31

重要事件披露

8-K - Current report
2020/07/28

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/27

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/27

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/27

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/07/02

重要事件披露

8-K - Current report
2020/05/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/15

重要事件披露

8-K - Current report
2020/04/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/07

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/31

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/03/31

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/31

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/30

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/03/13

SEC問詢函

CORRESP [Cover] - Correspondence
更多